The involvement of GPR39 in these pathways through mechanisms such as zinc-mediated neurotransmission and neuroplasticity provides further support for its therapeutic potential in addressing the overlapping pathophysiology of OAB and depression. The gene discussed is GPR39; the disease is depressive symptom measurement.